{"id":51191,"date":"2022-11-23T15:02:31","date_gmt":"2022-11-23T14:02:31","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/"},"modified":"2022-11-23T15:02:31","modified_gmt":"2022-11-23T14:02:31","slug":"304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/","title":{"rendered":"$304 Billion Worldwide Monoclonal Antibodies Industry to 2027 &#8211; Featuring AbbVie, Amgen, Biogen, GSK, Johnson &amp; Johnson and Sanofi Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5682119\/monoclonal-antibodies-market-global-industry?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=vbxsz2&amp;utm_campaign=1779706+-+%24304+Billion+Worldwide+Monoclonal+Antibodies+Industry+to+2027+-+Featuring+AbbVie%2C+Amgen%2C+Biogen%2C+GSK%2C+Johnson+%26+Johnson+and+Sanofi+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Monoclonal Antibodies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221123005290\/en\/1646096\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221123005290\/en\/1646096\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global monoclonal antibodies market size reached US$ 194.03 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 304.16 Billion by 2027, exhibiting a CAGR of 7.78% during 2021-2027.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAbbVie Inc.\n<\/li>\n<li>\nAmgen Inc.\n<\/li>\n<li>\nBiogen Inc.\n<\/li>\n<li>\nF. Hoffmann-La Roche AG\n<\/li>\n<li>\nGSK plc\n<\/li>\n<li>\nJohnson &amp; Johnson\n<\/li>\n<li>\nMerck KGaA\n<\/li>\n<li>\nNovartis AG\n<\/li>\n<li>\nNovo Nordisk A\/S\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nSanofi S.A.\n<\/li>\n<li>\nThermo Fisher Scientific Inc.\n<\/li>\n<\/ul>\n<p>\nKeeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.\n<\/p>\n<p>\nMonoclonal antibodies (mAbs) are laboratory-produced proteins used to serve as substitute antibodies that can enhance, modify, restore, and mimic the attack of the immune system on unwanted cells. They are utilized for detecting and targetting cancer cells for destruction by enhancing the immune system.\n<\/p>\n<p>\nThey are also employed to block the connection between a cancer cell and proteins that promote cell growth. In addition, they prevent the formation of proteins for enabling immune system cells to work efficiently against cancer cells. Besides this, mAbs transport the radiation treatment directly to cancer cells and minimize the effect of radiation on healthy cells.\n<\/p>\n<p>\nAt present, the growing prevalence of chronic diseases, such as cancer, heart disease, stroke, diabetes, and arthritis, represents one of the key factors driving the market. Besides this, leading manufacturers are extensively investing in research and development (R&amp;D) activities to introduce enhanced mAb drugs for treating neurodegenerative diseases, such as Alzheimer&#8217;s, Huntington&#8217;s, Parkinson&#8217;s, and Lewy body diseases.\n<\/p>\n<p>\nThey are also focusing on various marketing strategies to expand their customer base, which is contributing to the growth of the market. In addition, the increasing demand for humanized mAbs to treat various antigens, such as cancer cells, immunosuppression, and immunomodulatory molecules, are offering lucrative growth opportunities to industry investors. Apart from this, there is a rise in the demand for cost-efficient biosimilar mAbs to treat cancer across the globe. This, along with the burgeoning healthcare industry, is propelling the growth of the market.\n<\/p>\n<p>\nMoreover, technological advancements in various genetic platforms, such as next-generation sequencing, is offering a positive market outlook. Additionally, there is an increase in the employment of advanced genetic engineering technology in mAbs production around the world. This, coupled with the rising awareness among the masses about the benefits of mAb therapy, is bolstering the market growth.\n<\/p>\n<p>\n<strong>Key Market Segmentation:<\/strong>\n<\/p>\n<p>\nThe publisher provides an analysis of the key trends in each sub-segment of the global monoclonal antibodies market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on production method, source, indication and end use.\n<\/p>\n<p>\n<strong>Breakup by Production Method:<\/strong>\n<\/p>\n<ul>\n<li>\nIn Vivo\n<\/li>\n<li>\nIn Vitro\n<\/li>\n<\/ul>\n<p>\n<strong>Breakup by Source:<\/strong>\n<\/p>\n<ul>\n<li>\nMurine\n<\/li>\n<li>\nChimeric\n<\/li>\n<li>\nHumanized\n<\/li>\n<li>\nHuman\n<\/li>\n<\/ul>\n<p>\n<strong>Breakup by Indication:<\/strong>\n<\/p>\n<ul>\n<li>\nCancer\n<\/li>\n<li>\nAutoimmune Diseases\n<\/li>\n<li>\nInflammatory Diseases\n<\/li>\n<li>\nInfectious Diseases\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>Breakup by End Use:<\/strong>\n<\/p>\n<ul>\n<li>\nHospitals\n<\/li>\n<li>\nResearch Institutes\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>Breakup by Region:<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America\n<\/li>\n<li>\nUnited States\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nAsia-Pacific\n<\/li>\n<li>\nChina\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nIndia\n<\/li>\n<li>\nSouth Korea\n<\/li>\n<li>\nAustralia\n<\/li>\n<li>\nIndonesia\n<\/li>\n<li>\nOthers\n<\/li>\n<li>\nEurope\n<\/li>\n<li>\nGermany\n<\/li>\n<li>\nFrance\n<\/li>\n<li>\nUnited Kingdom\n<\/li>\n<li>\nItaly\n<\/li>\n<li>\nSpain\n<\/li>\n<li>\nRussia\n<\/li>\n<li>\nOthers\n<\/li>\n<li>\nLatin America\n<\/li>\n<li>\nBrazil\n<\/li>\n<li>\nMexico\n<\/li>\n<li>\nOthers\n<\/li>\n<li>\nMiddle East and Africa\n<\/li>\n<\/ul>\n<p>\n<strong>Key Questions Answered in This Report:<\/strong>\n<\/p>\n<ul>\n<li>\nHow has the global monoclonal antibodies market performed so far and how will it perform in the coming years?\n<\/li>\n<li>\nWhat has been the impact of COVID-19 on the global monoclonal antibodies market?\n<\/li>\n<li>\nWhat are the key regional markets?\n<\/li>\n<li>\nWhat is the breakup of the market based on the production method?\n<\/li>\n<li>\nWhat is the breakup of the market based on the source?\n<\/li>\n<li>\nWhat is the breakup of the market based on the indication?\n<\/li>\n<li>\nWhat is the breakup of the market based on the end use?\n<\/li>\n<li>\nWhat are the various stages in the value chain of the industry?\n<\/li>\n<li>\nWhat are the key driving factors and challenges in the industry?\n<\/li>\n<li>\nWhat is the structure of the global monoclonal antibodies market and who are the key players?\n<\/li>\n<li>\nWhat is the degree of competition in the industry?\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5682119\/monoclonal-antibodies-market-global-industry?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=vbxsz2&amp;utm_campaign=1779706+-+%24304+Billion+Worldwide+Monoclonal+Antibodies+Industry+to+2027+-+Featuring+AbbVie%2C+Amgen%2C+Biogen%2C+GSK%2C+Johnson+%26+Johnson+and+Sanofi+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/nzksvr<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x70;&#114;&#x65;&#115;&#x73;&#64;&#x72;&#101;&#x73;&#101;&#x61;&#114;&#x63;&#104;&#x61;&#110;&#x64;&#109;&#x61;&#114;&#x6b;&#101;&#x74;&#115;&#x2e;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#101;s&#x73;&#x40;&#x72;&#101;s&#x65;&#x61;&#x72;&#99;h&#x61;&#x6e;&#x64;&#109;a&#x72;&#x6b;&#x65;&#116;s&#x2e;&#x63;&#x6f;&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Monoclonal Antibodies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global monoclonal antibodies market size reached US$ 194.03 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 304.16 Billion by 2027, exhibiting a CAGR of 7.78% during 2021-2027. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51191","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>$304 Billion Worldwide Monoclonal Antibodies Industry to 2027 - Featuring AbbVie, Amgen, Biogen, GSK, Johnson &amp; Johnson and Sanofi Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"$304 Billion Worldwide Monoclonal Antibodies Industry to 2027 - Featuring AbbVie, Amgen, Biogen, GSK, Johnson &amp; Johnson and Sanofi Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Monoclonal Antibodies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global monoclonal antibodies market size reached US$ 194.03 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 304.16 Billion by 2027, exhibiting a CAGR of 7.78% during 2021-2027. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-23T14:02:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221123005290\/en\/1646096\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"$304 Billion Worldwide Monoclonal Antibodies Industry to 2027 &#8211; Featuring AbbVie, Amgen, Biogen, GSK, Johnson &amp; Johnson and Sanofi Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-11-23T14:02:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\\\/\"},\"wordCount\":762,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221123005290\\\/en\\\/1646096\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\\\/\",\"name\":\"$304 Billion Worldwide Monoclonal Antibodies Industry to 2027 - Featuring AbbVie, Amgen, Biogen, GSK, Johnson &amp; Johnson and Sanofi Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221123005290\\\/en\\\/1646096\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-11-23T14:02:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221123005290\\\/en\\\/1646096\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221123005290\\\/en\\\/1646096\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"$304 Billion Worldwide Monoclonal Antibodies Industry to 2027 &#8211; Featuring AbbVie, Amgen, Biogen, GSK, Johnson &amp; Johnson and Sanofi Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"$304 Billion Worldwide Monoclonal Antibodies Industry to 2027 - Featuring AbbVie, Amgen, Biogen, GSK, Johnson &amp; Johnson and Sanofi Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"$304 Billion Worldwide Monoclonal Antibodies Industry to 2027 - Featuring AbbVie, Amgen, Biogen, GSK, Johnson &amp; Johnson and Sanofi Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Monoclonal Antibodies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global monoclonal antibodies market size reached US$ 194.03 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 304.16 Billion by 2027, exhibiting a CAGR of 7.78% during 2021-2027. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-23T14:02:31+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221123005290\/en\/1646096\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"$304 Billion Worldwide Monoclonal Antibodies Industry to 2027 &#8211; Featuring AbbVie, Amgen, Biogen, GSK, Johnson &amp; Johnson and Sanofi Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-11-23T14:02:31+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/"},"wordCount":762,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221123005290\/en\/1646096\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/","name":"$304 Billion Worldwide Monoclonal Antibodies Industry to 2027 - Featuring AbbVie, Amgen, Biogen, GSK, Johnson &amp; Johnson and Sanofi Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221123005290\/en\/1646096\/21\/logo.jpg","datePublished":"2022-11-23T14:02:31+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221123005290\/en\/1646096\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221123005290\/en\/1646096\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/304-billion-worldwide-monoclonal-antibodies-industry-to-2027-featuring-abbvie-amgen-biogen-gsk-johnson-johnson-and-sanofi-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"$304 Billion Worldwide Monoclonal Antibodies Industry to 2027 &#8211; Featuring AbbVie, Amgen, Biogen, GSK, Johnson &amp; Johnson and Sanofi Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51191"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51191\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}